MY114655A - Indolopyrrolocarbazole derivatives - Google Patents

Indolopyrrolocarbazole derivatives

Info

Publication number
MY114655A
MY114655A MYPI92002167A MYPI19922167A MY114655A MY 114655 A MY114655 A MY 114655A MY PI92002167 A MYPI92002167 A MY PI92002167A MY PI19922167 A MYPI19922167 A MY PI19922167A MY 114655 A MY114655 A MY 114655A
Authority
MY
Malaysia
Prior art keywords
indolopyrrolocarbazole derivatives
indolopyrrolocarbazole
derivatives
compound
formula
Prior art date
Application number
MYPI92002167A
Other languages
English (en)
Inventor
Kojiri Katsuhisa
Kondo Hisao
Arakawa Hiroharu
Ohkubo Mitsuru
Suda Hiroyuki
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of MY114655A publication Critical patent/MY114655A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044Pyrrole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Silicon Polymers (AREA)
MYPI92002167A 1991-11-29 1992-11-25 Indolopyrrolocarbazole derivatives MY114655A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34191691 1991-11-29
JP6926992 1992-02-18
JP25730692 1992-09-01

Publications (1)

Publication Number Publication Date
MY114655A true MY114655A (en) 2002-12-31

Family

ID=27300000

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92002167A MY114655A (en) 1991-11-29 1992-11-25 Indolopyrrolocarbazole derivatives

Country Status (27)

Country Link
EP (1) EP0545195B1 (OSRAM)
JP (1) JP2629542B2 (OSRAM)
KR (1) KR100275976B1 (OSRAM)
AT (1) ATE130617T1 (OSRAM)
AU (1) AU650376B2 (OSRAM)
BG (1) BG61036B1 (OSRAM)
CA (1) CA2083534C (OSRAM)
CZ (1) CZ287304B6 (OSRAM)
DE (1) DE69206242T2 (OSRAM)
DK (1) DK0545195T3 (OSRAM)
DZ (1) DZ1634A1 (OSRAM)
ES (1) ES2079774T3 (OSRAM)
FI (1) FI106864B (OSRAM)
GR (1) GR3018527T3 (OSRAM)
HU (3) HU217611B (OSRAM)
IL (1) IL103844A (OSRAM)
MX (1) MX9206847A (OSRAM)
MY (1) MY114655A (OSRAM)
NO (1) NO178929C (OSRAM)
NZ (1) NZ245203A (OSRAM)
PL (1) PL171468B1 (OSRAM)
RO (1) RO113469B1 (OSRAM)
RU (1) RU2117671C1 (OSRAM)
SA (1) SA93130351B1 (OSRAM)
TW (1) TW224469B (OSRAM)
WO (1) WO1993011145A1 (OSRAM)
YU (1) YU48963B (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
CA2190007C (en) * 1994-05-09 2003-04-15 Katsuhisa Kojiri Antitumor indolopyrrolocarbazole derivatives
AU2575395A (en) * 1994-06-13 1996-01-05 Banyu Pharmaceutical Co., Ltd. Gene coding for glycosyltransferase and use thereof
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
WO1997009339A1 (fr) * 1995-09-05 1997-03-13 Banyu Pharmaceutical Co., Ltd. Derives antitumoraux d'indolopyrrolocarbazole
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
HUP9903931A3 (en) * 1996-08-22 2000-09-28 Bristol Myers Squibb Co Wallin Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
GB9811624D0 (en) * 1998-05-29 1998-07-29 Merck Sharp & Dohme Therapeutic use
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6703373B1 (en) 1999-09-10 2004-03-09 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives and antitumor agents
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TR200302314T4 (tr) 2000-02-24 2004-01-21 Banyu Pharmaceutical Co., Ltd. İndolopirolokarbazol türevinin hazırlanması için bir işlem, hazırlık işlemindeki ara ürünler ve ara ürünlerin hazırlanmsı için bir işlem.
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6555677B2 (en) 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
JP2004534006A (ja) 2001-03-22 2004-11-11 ブリストル−マイヤーズ スクイブ カンパニー インドロピロロカルバゾール化合物のトポイソメラーゼi選択的細胞毒シュガー誘導体
US6559299B2 (en) 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides
MXPA04009324A (es) * 2002-03-26 2005-01-25 Banyu Pharma Co Ltd Uso de derivado de indolopirrolocarbazol y otro agente anticanceroso en combinacion.
CA2398828A1 (en) 2002-08-09 2004-02-09 Merck & Co., Inc. A pharmaceutical composition containing an indolopyrrolocarbazole derivative
CA2496479A1 (en) * 2002-08-23 2004-03-04 Banyu Pharmaceutical Co., Ltd. Process for producing indolopyrrolocarbazole derivative
WO2005010017A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd インドロピロロカルバゾール誘導体及び抗腫瘍剤
CN1852914A (zh) * 2003-09-16 2006-10-25 万有制药株式会社 抗肿瘤性新型吲哚并吡咯并咔唑衍生物
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
US7241779B2 (en) 2003-12-23 2007-07-10 Cephalon, Inc. Fused pyrrolocarbazoles
RU2255089C1 (ru) * 2003-12-26 2005-06-27 Закрытое акционерное общество "АСГЛ-Исследовательские Лаборатории" Производные гликозидов индоло[2,3-а]пирроло[3,4-с]карбазол-5,7-дионов, обладающие цитотоксической и противоопухолевой активностью
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
MX2011005055A (es) 2008-11-19 2011-05-31 Cephalon Inc Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
EP0445736A1 (en) * 1990-03-06 1991-09-11 Bristol-Myers Squibb Company Rebeccamycin analog and pharmaceutical composition containing it
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
MX9201643A (es) * 1991-04-11 1992-10-01 Schering Corp Agentes contra tumores y anti-psoriasicos.

Also Published As

Publication number Publication date
BG97970A (bg) 1994-04-29
HUT65699A (en) 1994-07-28
YU102692A (sh) 1996-02-19
EP0545195A1 (en) 1993-06-09
WO1993011145A1 (en) 1993-06-10
NO924593L (no) 1993-06-01
HU211254A9 (en) 1995-11-28
TW224469B (OSRAM) 1994-06-01
RO113469B1 (ro) 1998-07-30
KR100275976B1 (ko) 2001-02-01
CA2083534A1 (en) 1993-05-30
AU650376B2 (en) 1994-06-16
IL103844A0 (en) 1993-04-04
DE69206242D1 (de) 1996-01-04
JP2629542B2 (ja) 1997-07-09
IL103844A (en) 1997-09-30
DK0545195T3 (da) 1995-12-18
NO924593D0 (no) 1992-11-27
PL171468B1 (pl) 1997-05-30
CZ350892A3 (en) 1993-10-13
PL304729A1 (en) 1995-01-09
DE69206242T2 (de) 1996-03-28
YU48963B (sh) 2003-01-31
GR3018527T3 (en) 1996-03-31
NO178929B (no) 1996-03-25
MX9206847A (es) 1993-06-30
FI925422L (fi) 1993-05-30
KR930010039A (ko) 1993-06-21
ES2079774T3 (es) 1996-01-16
NO178929C (no) 1996-07-03
DZ1634A1 (fr) 2002-02-17
CZ287304B6 (cs) 2000-10-11
NZ245203A (en) 1997-07-27
CA2083534C (en) 2003-01-28
JPH06128283A (ja) 1994-05-10
HU217611B (hu) 2000-03-28
EP0545195B1 (en) 1995-11-22
RU2117671C1 (ru) 1998-08-20
SA93130351B1 (ar) 2005-10-16
FI106864B (fi) 2001-04-30
FI925422A0 (fi) 1992-11-27
HU9203754D0 (en) 1993-03-29
ATE130617T1 (de) 1995-12-15
AU2963792A (en) 1993-06-03
BG61036B1 (bg) 1996-09-30

Similar Documents

Publication Publication Date Title
MY114655A (en) Indolopyrrolocarbazole derivatives
CA2101447A1 (en) 3-difluoromethylpyrazolecarboxamide fungicides
GR3032723T3 (en) 10-desacetoxytaxol derivatives.
MY134880A (en) Thiazolyl amide derivatives
MX9700885A (es) Nuevas heteroariloxazolidinonas.
AU2630192A (en) 3-phenylpyrazoles derivatives as fungicides
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
AU1231492A (en) Substituted phenyl-1,3 dioxoloquinoline derivatives and their use as antitumor agents
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
AU6878894A (en) 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
OA09912A (en) Fungicides.
EP0711768A4 (en) BENZIMIDAZOLE DERIVATIVES
AU2267195A (en) Dc-89 derivative
GR3017462T3 (en) 2-Hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists.
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
CA2262566A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
TW221441B (OSRAM)
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
MX9803672A (es) Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos.
TW269687B (OSRAM)
AU3952997A (en) Arylsulfonylimidazolone derivatives as an antitumor agent
AU1928792A (en) Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
EP0764643A4 (OSRAM)
AU1254188A (en) Disaccharide derivatives
IL152614A0 (en) Derivatives of uridine as antibiotics